Ren H, Elliott N, Lye B, Sharif Shohan MU, et al. Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia. Blood 2025 Sep 3:blood.2025029302. doi: 10.1182/blood.2025029302.
PMID: 40898981